Max Healthcare Institute Beheer
Beheer criteriumcontroles 2/4
De CEO Max Healthcare Institute is Abhay Soi, benoemd in Jun2020, heeft een ambtstermijn van 4.42 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 247.33M, bestaande uit 79.7% salaris en 20.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 23.74% van de aandelen van het bedrijf, ter waarde ₹ 230.73B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.1 jaar en 3.5 jaar.
Belangrijke informatie
Abhay Soi
Algemeen directeur
₹247.3m
Totale compensatie
| Percentage CEO-salaris | 79.7% |
| Dienstverband CEO | 4.4yrs |
| Eigendom CEO | 23.7% |
| Management gemiddelde ambtstermijn | 5.1yrs |
| Gemiddelde ambtstermijn bestuur | 3.5yrs |
Recente managementupdates
Recent updates
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Nov 09
Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now
Sep 14Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Jul 18Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark
Jun 21Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know
May 25Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today
Apr 14Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors
Mar 18Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly
Jan 08Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable
Dec 18With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Sep 20Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?
Jul 07Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt
Jun 19Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now
Apr 11With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case
Mar 15Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Feb 22Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet
Nov 22Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors
Oct 26Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly
Jul 15Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly
Mar 09Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals
Nov 24Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹11b |
| Jun 30 2024 | n/a | n/a | ₹11b |
| Mar 31 2024 | ₹247m | ₹197m | ₹11b |
| Dec 31 2023 | n/a | n/a | ₹11b |
| Sep 30 2023 | n/a | n/a | ₹10b |
| Jun 30 2023 | n/a | n/a | ₹12b |
| Mar 31 2023 | ₹140m | ₹140m | ₹11b |
| Dec 31 2022 | n/a | n/a | ₹10b |
| Sep 30 2022 | n/a | n/a | ₹9b |
| Jun 30 2022 | n/a | n/a | ₹6b |
| Mar 31 2022 | ₹140m | ₹49m | ₹6b |
| Dec 31 2021 | n/a | n/a | ₹6b |
| Sep 30 2021 | n/a | n/a | ₹5b |
| Jun 30 2021 | n/a | n/a | ₹3b |
| Mar 31 2021 | ₹117m | ₹91m | -₹1b |
Compensatie versus markt: De totale vergoeding ($USD 2.93M ) Abhay } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 1.10M ).
Compensatie versus inkomsten: De vergoeding van Abhay is het afgelopen jaar met meer dan 20% gestegen.
CEO
Abhay Soi (51 yo)
4.4yrs
Tenure
₹247,330,308
Compensatie
Mr. Abhay Soi is a Co-Founder of Halcyon Group. He served as Executive Officer at Ernst & Young LLP. Mr. Soi served as Head of Financial Restructuring group at Ernst & Young and Arthur Anderson.He has in-...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & MD | 4.4yrs | ₹247.33m | 23.74% ₹ 230.7b | |
| Senior Director & CFO | 12.8yrs | ₹45.10m | 0.0062% ₹ 60.0m | |
| Senior VP | 1.8yrs | ₹10.00m | geen gegevens | |
| Member of Group Medical Advisory Council | no data | geen gegevens | geen gegevens | |
| Director of Information Technology & Chief Information Officer | 5.2yrs | geen gegevens | geen gegevens | |
| General Counsel & Director | less than a year | geen gegevens | geen gegevens | |
| Senior Director and Chief Sales & Marketing Officer | no data | geen gegevens | geen gegevens | |
| Member of Group Medical Advisory Council | 5.3yrs | geen gegevens | geen gegevens | |
| Member of Group Medical Advisory Council & Group Medical Director | no data | geen gegevens | geen gegevens | |
| Member of Group Medical Advisory Council | 5.1yrs | geen gegevens | geen gegevens | |
| Chairman of Paediatrics & Paediatric Surgery | 3.8yrs | geen gegevens | geen gegevens | |
| Senior Director & COO - Cluster 2 | 5.3yrs | geen gegevens | geen gegevens |
5.1yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van MAXHEALTH is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.1 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & MD | 5.4yrs | ₹247.33m | 23.74% ₹ 230.7b | |
| Member of Group Medical Advisory Council | no data | geen gegevens | geen gegevens | |
| General Counsel & Director | less than a year | geen gegevens | geen gegevens | |
| Member of Group Medical Advisory Council | no data | geen gegevens | geen gegevens | |
| Member of Group Medical Advisory Council & Group Medical Director | no data | geen gegevens | geen gegevens | |
| Member of Group Medical Advisory Council | no data | geen gegevens | geen gegevens | |
| Director & Chief Procurement Officer | no data | geen gegevens | geen gegevens | |
| Non-Executive Independent Director | 5.4yrs | ₹5.25m | geen gegevens | |
| Non-Executive Non-Independent Director | 1.5yrs | ₹3.83m | geen gegevens | |
| Member of Group Medical Advisory Council | no data | ₹4.42m | geen gegevens | |
| Member of Group Medical Advisory Council | no data | geen gegevens | geen gegevens | |
| Member of Group Medical Advisory Council | no data | geen gegevens | geen gegevens |
3.5yrs
Gemiddelde duur
57.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van MAXHEALTH wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).